Symbiotec Pharmalab Limited (BOM:544889)
India · Delayed Price · Currency is INR 1,138.05
+3.65 (0.32%)
At close: Sep 10, 2026
Symbiotec Pharmalab Market Cap
Symbiotec Pharmalab has a market cap or net worth of 72.85 billion as of September 10, 2026.
Market Cap
72.85B
Enterprise Value
76.65B
Revenue
8.69B
Ranking
n/a
PE Ratio
66.30
Stock Price
1,138.05
ChartMarket Cap Chart
Since September 1, 2026, Symbiotec Pharmalab's market cap has increased from 70.53B to 72.85B, an increase of 3.28%. That is a compound annual growth rate of 270.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2026 | 72.85B | - |
| Sep 9, 2026 | 72.85B | 3.62% |
| Sep 8, 2026 | 70.30B | -0.42% |
| Sep 7, 2026 | 70.60B | 1.90% |
| Sep 4, 2026 | 69.28B | 0.13% |
| Sep 3, 2026 | 69.19B | -1.46% |
| Sep 2, 2026 | 70.22B | -0.45% |
| Sep 1, 2026 | 70.53B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Neuland Laboratories | 307.58B |
| Shilpa Medicare | 183.38B |
| Suven Life Sciences | 97.73B |
| Symbiotec Pharmalab | 70.60B |
| IOL Chemicals and Pharmaceuticals | 62.54B |
| Gujarat Themis Biosyn | 55.92B |
| NGL Fine-Chem | 17.32B |
| Bajaj HealthCare | 11.35B |